Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.

PloS one - 1 Jan 2021

Huang Ying-Chou, Huang Chung-Feng, Liu Shu-Fen, Liu Hung-Yin, Yeh Ming-Lun, Huang Ching-I, Hsieh Meng-Hsuan, Dai Chia-Yen, Chen Shinn-Chern, Yu Ming-Lung, Chuang Wan-Long, Huang Jee-Fu

Abstract excerpt

BACKGROUND AND AIMS: Hepatitis C virus (HCV) genotyping is a pivotal tool for epidemiological investigation, guiding management and antiviral treatment. Challenge existed in identifying subtypes of genotype-1 (G-1) and genotype (GT) of indeterminate. Recently, the Abbott HCV RealTime Genotype Plus RUO assay (HCV GT Plus) has been developed aiming to overcome the limitations. We aimed to evaluate the performance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Hepacivirus

Share to Hepatitis C

Share to Real-Time Polymerase Chain Reaction

Share to Taiwan

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 33513184
DOI: 10.1371/journal.pone.0246376
PMCID: PMC7845948

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.PMID 33513184Read ↗

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.Semantic proximity Read ↗

Utility of the Abbott RealTime HCV Genotype Plus RUO assay used in combination with the Abbott RealTime HCV Genotype II assay.Semantic proximity Read ↗

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.Semantic proximity Read ↗

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.Semantic proximity Read ↗

High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assaysSemantic proximity Read ↗

HCV Detection, Discrimination, and Genotyping TechnologiesSemantic proximity Read ↗

Indeterminate genotypes of hepatitis C virus by the Abbott RealTime HCV Genotype II assay in Morocco. About eight cases resolved by a sequencing method.Semantic proximity Read ↗

Performance of the Abbott RealTime HCV Genotype II RUO assay.Semantic proximity Read ↗

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus GenotypingSemantic proximity Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

Fast, reliable and low cost user-developed protocol for detection, quantification and genotyping of hepatitis C virus.Semantic proximity Read ↗

Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.